The Peptide Report
A growing number of Silicon Valley executives have quietly retired their morning espresso in favor of an intranasal NAD+ ritual. Here's what's driving the shift — and the science behind it.
An inside look at the quiet shift happening in Silicon Valley boardrooms and Wall Street trading floors — where a fast-absorbing nasal spray is replacing the 3 PM coffee ritual. Here's the science behind the trend and why it's catching on.
A generation of high-performing executives has quietly traded IV drips and pills for a faster-absorbing NAD+ nasal spray. Here's why the format change matters — and what the science says.
The afternoon productivity crash isn't a discipline problem — it's a mitochondrial one. A new generation of high-performers is reaching for NAD+ instead of a fourth espresso.
A growing cohort of Silicon Valley operators is replacing their morning caffeine ritual with a few seconds of intranasal NAD+. Here's the science — and the cultural shift — behind the change.
A quiet shift is underway in Silicon Valley morning routines: caffeine is out, mitochondrial support is in. Inside the rise of NAD+ nasal sprays and the biohacking protocol redefining peak performance.
